000 | 02167 a2200637 4500 | ||
---|---|---|---|
005 | 20250517000702.0 | ||
264 | 0 | _c20150421 | |
008 | 201504s 0 0 eng d | ||
022 | _a2326-5205 | ||
024 | 7 |
_a10.1002/art.38916 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUnizony, Sebastian | |
245 | 0 | 0 |
_aPeripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. _h[electronic resource] |
260 |
_bArthritis & rheumatology (Hoboken, N.J.) _cFeb 2015 |
||
300 |
_a535-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis _xdrug therapy |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 |
_aCD5 Antigens _xmetabolism |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLim, Noha | |
700 | 1 | _aPhippard, Deborah J | |
700 | 1 | _aCarey, Vincent J | |
700 | 1 | _aMiloslavsky, Eli M | |
700 | 1 | _aTchao, Nadia K | |
700 | 1 | _aIklé, David | |
700 | 1 | _aAsare, Adam L | |
700 | 1 | _aMerkel, Peter A | |
700 | 1 | _aMonach, Paul A | |
700 | 1 | _aSeo, Philip | |
700 | 1 | _aSt Clair, E William | |
700 | 1 | _aLangford, Carol A | |
700 | 1 | _aSpiera, Robert | |
700 | 1 | _aHoffman, Gary S | |
700 | 1 | _aKallenberg, Cees G M | |
700 | 1 | _aSpecks, Ulrich | |
700 | 1 | _aStone, John H | |
773 | 0 |
_tArthritis & rheumatology (Hoboken, N.J.) _gvol. 67 _gno. 2 _gp. 535-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.38916 _zAvailable from publisher's website |
999 |
_c24294423 _d24294423 |